Javid Fazili

572 total citations
26 papers, 442 citations indexed

About

Javid Fazili is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Javid Fazili has authored 26 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 10 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Javid Fazili's work include Liver Disease Diagnosis and Treatment (10 papers), Hepatitis C virus research (10 papers) and Liver Disease and Transplantation (5 papers). Javid Fazili is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Hepatitis C virus research (10 papers) and Liver Disease and Transplantation (5 papers). Javid Fazili collaborates with scholars based in United States, Belgium and Pakistan. Javid Fazili's co-authors include Ted Bader, Christopher E. Aston, Muhammad Hasan, S.A.H. Rizvi, Mohammad F. Madhoun, Salman Nusrat, Vivek Kaul, Leonard E. Braitman, Kenneth D. Rothstein and Frank K. Friedenberg and has published in prestigious journals such as Gastroenterology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Javid Fazili

22 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javid Fazili United States 10 278 240 59 51 48 26 442
Lydia L. Barlow United States 8 284 1.0× 311 1.3× 78 1.3× 41 0.8× 27 0.6× 10 486
Mitsuaki Sato Japan 10 463 1.7× 436 1.8× 42 0.7× 37 0.7× 51 1.1× 35 581
María Trapero-Marugán Spain 14 250 0.9× 236 1.0× 74 1.3× 56 1.1× 58 1.2× 28 441
Kiyohide Kioka Japan 9 335 1.2× 283 1.2× 28 0.5× 50 1.0× 25 0.5× 58 418
Déborah Crespo Brazil 7 321 1.2× 412 1.7× 89 1.5× 36 0.7× 57 1.2× 9 545
Xiaoguang Dou China 16 377 1.4× 388 1.6× 112 1.9× 65 1.3× 46 1.0× 72 638
Luciana Kikuchi Brazil 13 263 0.9× 240 1.0× 68 1.2× 52 1.0× 63 1.3× 22 417
Hiromi Kan Japan 16 273 1.0× 317 1.3× 52 0.9× 77 1.5× 26 0.5× 32 460
Hsing‐Tao Kuo Taiwan 13 482 1.7× 446 1.9× 61 1.0× 42 0.8× 25 0.5× 52 643
Eiji Tanaka Japan 8 240 0.9× 314 1.3× 58 1.0× 76 1.5× 27 0.6× 10 431

Countries citing papers authored by Javid Fazili

Since Specialization
Citations

This map shows the geographic impact of Javid Fazili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javid Fazili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javid Fazili more than expected).

Fields of papers citing papers by Javid Fazili

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javid Fazili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javid Fazili. The network helps show where Javid Fazili may publish in the future.

Co-authorship network of co-authors of Javid Fazili

This figure shows the co-authorship network connecting the top 25 collaborators of Javid Fazili. A scholar is included among the top collaborators of Javid Fazili based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javid Fazili. Javid Fazili is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moore, Landon L., Dongfeng Qu, Sripathi M. Sureban, et al.. (2024). From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases. International Journal of Molecular Sciences. 25(12). 6481–6481. 4 indexed citations
2.
Fazili, Javid, et al.. (2024). S3801 Meckel’s Diverticulum: A Cause of Unknown Hemorrhagic Shock. The American Journal of Gastroenterology. 119(10S). S2490–S2491.
3.
Khan, Taha, et al.. (2024). S3961 Common Variable Immunodeficiency Mimicking Inflammatory Bowel Disease. The American Journal of Gastroenterology. 119(10S). S2573–S2573.
4.
Ali, Naushad, Parthasarathy Chandrakesan, Roman F. Wolf, et al.. (2020). Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanism. Scientific Reports. 10(1). 10578–10578. 11 indexed citations
5.
Fazili, Javid, et al.. (2018). Hepatocellular Carcinoma Occurrence and Recurrence in Hepatitis C-infected Patients Treated with Direct-acting Antivirals. Cureus. 10(6). e2843–e2843. 6 indexed citations
6.
7.
Fazili, Javid, et al.. (2017). Spontaneous Intramural Esophageal Hematoma. Clinical Gastroenterology and Hepatology. 16(2). e19–e20. 6 indexed citations
8.
Fazili, Javid, et al.. (2017). Gastric heterotopia in the rectum. A rare cause of ectopic gastric tissue. Arab Journal of Gastroenterology. 18(1). 42–43. 3 indexed citations
9.
Fazili, Javid, et al.. (2015). Mystery of Hepatitis E Virus: Recent Advances in Its Diagnosis and Management. International Journal of Hepatology. 2015. 1–6. 43 indexed citations
10.
Fazili, Javid, et al.. (2014). Unusually High Alpha-fetoprotein in Hepatitis B Reactivation. The American Journal of Gastroenterology. 109. S160–S160. 1 indexed citations
11.
Chaudrey, Khadija, et al.. (2013). Expecting the Unexpected: Black Cohosh-induced Hepatotoxicity Leading to Early Cirrhosis. The American Journal of Gastroenterology. 108. S327–S327.
12.
Hanigan, Marie H., et al.. (2010). Optimizing Chemotherapy: Concomitant Medication Lists. Clinical Pharmacology & Therapeutics. 89(1). 114–119. 11 indexed citations
13.
Madhoun, Mohammad F., et al.. (2010). Hepatitis C Prevalence in Patients With Hepatocellular Carcinoma Without Cirrhosis. The American Journal of the Medical Sciences. 339(2). 169–173. 28 indexed citations
14.
Fazili, Javid, et al.. (2010). Outcome of a Hepatitis C Outbreak Among Patients in a Pain Management Clinic. Digestive Diseases and Sciences. 55(6). 1738–1743. 2 indexed citations
15.
Bader, Ted, et al.. (2008). A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone. Nature Clinical Practice Gastroenterology & Hepatology. 6(1). 57–60. 4 indexed citations
16.
Bader, Ted, et al.. (2008). Fluvastatin Inhibits Hepatitis C Replication in Humans. The American Journal of Gastroenterology. 103(6). 1383–1389. 167 indexed citations
17.
Fazili, Javid, et al.. (2005). Remission of natural-killer cell lymphoma of the liver with anti-hepatitis C therapy. American Journal of Hematology. 78(3). 212–215. 3 indexed citations
18.
Hasan, Muhammad K., et al.. (2003). REVERSAL OF ADVANCE LIVER FIBROSIS WITH PHLEBOTOMY IN A PATIENT WITH PORPHYRIA CUTANEA TARDA AND HEPATITIS C. The American Journal of Gastroenterology. 98. S201–S201. 1 indexed citations
19.
Kaul, Vivek, Frank K. Friedenberg, Leonard E. Braitman, et al.. (2002). Development and validation of a model to diagnose cirrhosis in patients with hepatitis C. The American Journal of Gastroenterology. 97(10). 2623–2628. 46 indexed citations
20.
Fazili, Javid, et al.. (2001). How gastroenterologists inform patients of results after lower endoscopy. The American Journal of Gastroenterology. 96(7). 2086–2092. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026